| Product ID |
Product Name |
CAS# |
Purity |
| Y3296164 |
Dicyclohexyl[3',4',5'-trifluoro-3,6-dimethoxy-2',6'-bis(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine |
2118959-56-9 |
95%+ |
| Y3289769 |
CDK4/6-IN-15 |
2078047-99-9 |
96% |
| Y3265248 |
PI3K/mTOR Inhibitor-13 sodium |
2361009-23-4 |
98.13% |
| Y3248728 |
Cbl-b-IN-2 |
2503325-21-9 |
95% |
| Y3295745 |
PROTAC HSP90 degrader BP3 |
2669072-88-0 |
98% |
| Y3294093 |
Cys-McMMAF |
1160590-05-5 |
99% |
| Y3297211 |
SIRT5 inhibitor 3 |
2128651-12-5 |
95% |
| Y3113741 |
CB2R/FAAH modulator-2 |
2876918-68-0 |
98% |
| Y3315871 |
Methyl 5-(thiophen-2-yl)-1,3,4-oxadiazole-2-carboxylate |
35403-82-8 |
95% |
| Y3267276 |
USP7-IN-7 |
2413944-70-2 |
97.53% |
| Y3265528 |
4-PQBH |
2243355-51-1 |
99.08% |
| Y3294726 |
HPK1-IN-34 |
2380300-99-0 |
95% |
| Y3113749 |
a-Glucosidase-IN-22 |
2870693-28-8 |
98% |
| Y3294219 |
Puliginurad |
2013582-27-7 |
99% |
| Y3271585 |
SJ000063181 |
945189-68-4 |
99% |
| Y3272021 |
W1131 |
2740522-79-4 |
99.25% |
| Y3290761 |
LpxC-IN-10 |
2413574-64-6 |
96% |
| Y3295846 |
CJJ300 |
1807631-83-9 |
99% |
| Y3310772 |
3-O-Feruloyl-6'-O-(4-O-ß-D-glucopyranosylferuloyl)sucrose |
117591-89-6 |
98% |
| Y3293475 |
BODIPY FL thalidomide |
2740620-18-0 |
99% |
| Y3267133 |
WNK1-IN-1 |
324022-39-1 |
99% |
| Y3304645 |
2,2-Dimethyl-N-1H-pyrazol-3-ylpropanamide |
1001635-04-6 |
95% |
| Y3267036 |
AChE/BChE-IN-10 |
2924824-48-4 |
99% |
| Y3296418 |
ZINC00784494 |
317328-17-9 |
99% |
| Y3269847 |
Ansornitinib |
1448874-96-1 |
98% |
| Y3271528 |
MSC-1186 |
2871698-23-4 |
99% |
| Y3311598 |
CTP |
1052692-86-0 |
98% |
| Y3266300 |
NF-B/MAPK-IN-1 |
2413940-56-2 |
98.42% |
| Y3295417 |
n-(4-Bromo-3-nitrophenyl)methanesulfonamide |
1247445-74-4 |
95% |
| Y3265773 |
SB1-G-187 |
2769753-18-4 |
98.01% |
| Y3286038 |
Tert-butyl 3-(benzylamino)-3-cyanoazetidine-1-carboxylate |
1517372-68-7 |
95%+ |
| Y3297413 |
eIF4A3-IN-13 |
1402931-85-4 |
99% |
| Y3307422 |
CCT373566 |
2378853-66-6 |
99.12% |
| Y3287309 |
Fmoc-Gly-OH-2-13C,15N |
285978-12-3 |
99% |
| Y3292470 |
Val-Ala-PAB-MMAE |
1912408-92-4 |
95% |
| Y3267448 |
Sitagliptin fenilalanil hydrochloride |
1339954-75-4 |
98% |
| Y3292243 |
FC9402 |
2452401-65-7 |
99% |
| Y3270173 |
GST-HG131 |
2270215-69-3 |
99% |
| Y3265063 |
cPrPMEDAP |
182798-83-0 |
99% |
| Y3309593 |
Methyl 6-hydroxy-1H-indazole-5-carboxylate |
2665660-81-9 |
95% |
| Y3296339 |
ERK1/2 inhibitor 9 |
2169302-75-2 |
95% |
| Y3118029 |
6-Fluoro-4-iodo-1H-pyrazolo[3,4-b]pyridine |
2417489-99-5 |
98% |
| Y3248724 |
GLP-1 moiety from Dulaglutide |
1197810-60-8 |
95% |
| Y3261838 |
Mutant p53 modulator-1 |
2746371-35-5 |
98% |
| Y3270432 |
Ethyl 4-amino-2-oxabicyclo[2.1.1]hexane-1-carboxylate 2,2,2-trifluoroacetate |
2567495-49-0 |
95% |
| Y3296093 |
2-Fluorobenzyl olaparib-d4 |
2732919-14-9 |
95% |
| Y3292121 |
1-Methylisoquinolin-3-amine |
15787-16-3 |
95% |
| Y3297069 |
VSPPLTLGQLLS |
1206896-24-3 |
98% |
| Y3296271 |
OSu-PEG4-VC-PAB-MMAE |
2762518-86-3 |
95% |
| Y3292539 |
Erythro-guaiacylglycerol-ß-ferulic acid ether |
1372162-61-2 |
97% |
| Y3258046 |
(-)-GSK598809 hydrochloride |
863766-31-8 |
99.64% |
| Y3118046 |
R 59-022 hydrochloride |
93076-98-3 |
98% |
| Y3258047 |
HIV-1 inhibitor-8 |
2826996-78-3 |
98.03% |
| Y3267983 |
TAM558 |
1802499-21-3 |
99% |
| Y3305877 |
Arabelline |
133084-20-5 |
95% |
| Y3270084 |
6-ROX hydrochloride |
1689512-96-6 |
99.05% |
| Y3294971 |
WIC1 |
943083-58-7 |
99% |
| Y3250812 |
Hsp90-IN-17 hydrochloride |
1253584-63-2 |
99% |
| Y3306238 |
Methyl 5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate |
2095432-35-0 |
95% |
| Y3307225 |
JNJ-28583113 |
2765255-93-2 |
98% |
| Y3295922 |
LabMol-319 |
381188-63-2 |
95% |
| Y3304626 |
BODIPY TR Cadaverine |
217190-24-4 |
96% |
| Y3261514 |
SARS-CoV-2-IN-6 |
2725749-22-2 |
99.87% |
| Y3290726 |
TLR7/8 antagonist 2 |
2769085-03-0 |
99% |
| Y3260254 |
ERGi-USU-6 mesylate |
2756327-67-8 |
95.0% |
| Y3287421 |
LONP1-IN-2 |
2729981-17-1 |
99% |
| Y3292957 |
HDAC6 degrader-3 |
2785404-83-1 |
98% |
| Y3268184 |
CS587 |
2388506-69-0 |
98.11% |
| Y3292507 |
ONO-0740556 |
2250210-69-4 |
99% |
| Y3257522 |
PARP10/15-IN-2 |
2892064-99-0 |
99.00% |
| Y3295252 |
RORt agonist 3 |
2664106-24-3 |
98% |
| Y3289112 |
Lumacaftor-d4 |
2733561-44-7 |
99% |
| Y3305996 |
Bisphenol AP-d5 |
2469555-57-3 |
95% |
| Y3248752 |
(E)-4-((Tert-butoxycarbonyl)amino)pent-2-enoic acid |
1334509-60-2 |
95% |
| Y3265410 |
306-N16B |
2803699-70-7 |
98% |
| Y3117857 |
DOCK2-IN-1 |
4590-86-7 |
98% |
| Y3260111 |
NJH-2-030 |
2709040-02-6 |
98.74% |
| Y3305974 |
(2-Fluoro-4-biphenyl)acetic acid-d5 |
2733149-72-7 |
99% |
| Y3118079 |
5-(Pyrrolidin-1-yl)pyrazin-2-amine |
1034711-12-0 |
97% |
| Y3268182 |
SJ988497 |
2595365-41-4 |
98% |
| Y3267941 |
Nenocorilant |
1496509-78-4 |
99.72% |
| Y3288296 |
TP-5801 |
2574474-81-8 |
99% |
| Y3297933 |
N-Desmethyl Bedaquiline-d6 |
2271264-26-5 |
96% |
| Y3290158 |
OTUB1/USP8-IN-1 |
2858800-98-1 |
98% |
| Y3311735 |
Cernuoside B |
260046-56-8 |
95% |
| Y3305793 |
(E)-(-)-Aspongopusamide B |
1632326-65-8 |
90% |
| Y3289801 |
STING agonist-26 |
2868261-48-5 |
99% |
| Y3287154 |
6-(tert-Butyl) 3-ethyl 2-oxo-1,5,7,8-tetrahydro-1,6-naphthyridine-3,6(2H)-dicarboxylate |
1812202-34-8 |
95%+ |
| Y3260406 |
Skp2 inhibitor 2 |
2760612-77-7 |
95% |
| Y3117978 |
Anticancer agent 46 |
2426686-17-9 |
95% |
| Y3289067 |
MAL3-101 |
912361-26-3 |
98% |
| Y3264956 |
1,3-Dioxoisoindolin-2-yl tetrahydrofuran-3-carboxylate |
2127881-32-5 |
95% |
| Y3270910 |
TEPC466 |
2621957-88-6 |
99% |
| Y3317286 |
1-(4-Isopropylphenyl)prop-2-en-1-ol |
1540980-88-8 |
95% |
| Y3291587 |
Skp2 inhibitor 1 |
2760612-63-1 |
99% |
| Y3271598 |
Br-DAPI |
2387906-44-5 |
95% |
| Y3297092 |
Antifungal agent 49 |
1414861-21-4 |
95% |
| Y3305935 |
Nampt activator-2 |
2237268-90-3 |
98% |
| Y3267702 |
PKRA83 |
1233926-87-8 |
98% |
| Y3309292 |
eIF4A3-IN-10 |
1402931-72-9 |
97% |